Aspen Aerogels (ASPN) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-2.36M
Depreciation and amortization (includes $128,935 and $511,588 from discontinued operations, respectively)	1.6M
Loss on disposal of equipment	0
Realized gain on sale of marketable securities
Deferred income taxes
Stock-based compensation	175.95K
Issuance of warrants
Common stock issued to consultant for services	0
Bad debt expense (recoveries)
Accounts receivable	-726.9K
Income taxes receivable	0
Inventories	-4.45K
Prepaids and other current assets	190.96K
Other non-current assets	26.25K
Accounts payable and accrued expenses	624.52K
Deferred rent payable
Net cash provided from operating activities
Purchases of property and equipment	-232.01K
Proceeds from sale and disposal of equipment	0
Sales of available-for-sale securities
Net cash used in investing activities
Proceeds from issuance of common stock
Net line of credit (repayments) borrowings	2.12M
Proceeds from issuance of long-term debt
Repayment of long-term debt	-36.22K
Net cash provided from financing activities
Net Increase (Decrease) in Cash and Cash Equivalents	214.09K
Cash and Cash Equivalents, Beginning of Period	567.19K
Cash and Cash Equivalents, End of Period	781.28K
Cash paid for interest	574.08K
Cash paid for income taxes
Non-cash commitments entered into for equipment loans
Increase (decrease) in fair value of available-for-sale securities
Non-cash conversion of related party subordinated debt into shares of common stock

Entities mentioned with ASPN

View All Entities